Close

More on ALT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)
- Holders

Upcoming Events

- Earnings (5/16/23)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Altimmune (NQ:ALT)
Delayed: 4.37 -0.05 (1.13%)
Prev. Close $4.42  
Open$4.45 
52 Wk High$54.24 
52 Wk Low$48.35 
Day High$4.57 
Day Low$4.23 
P/E N/A  
EPS$0.00 
Volume2,257,580 

Friends, Peers and Foes (?): CLIN, NVO, LLY, VKTX CLINU (more...)

Mar 27, 2023 05:18 PM Form 4 Altimmune, Inc. For: Mar 23 Filed by: Drutz David
Mar 27, 2023 04:17 PM Form 4 Altimmune, Inc. For: Mar 23 Filed by: Sohn Catherine A.
Mar 27, 2023 04:16 PM Form 3 Altimmune, Inc. For: Mar 23 Filed by: Sohn Catherine A.
Mar 27, 2023 04:07 PM Form 8-K Altimmune, Inc. For: Mar 23
Mar 27, 2023 04:05 PM Altimmune Appoints Former GSK Executive Catherine Angell Sohn, Pharm.D. to its Board of Directors
Mar 24, 2023 08:55 PM Form 4 Altimmune, Inc. For: Mar 24 Filed by: Eisenstadt Richard I
Mar 23, 2023 08:29 PM Form 4 Altimmune, Inc. For: Mar 23 Filed by: Harris Matthew Scott
Mar 22, 2023 03:07 AM Goldman Sachs Downgrades Altimmune (ALT) to Neutral
Mar 21, 2023 03:09 PM Viking Therapeutics (VKTX) sell-off is unwarranted, "attractive opportunity to add" - Truist
Mar 21, 2023 02:12 PM Evercore ISI Defending Altimmune (ALT), 'trading just above cash'
View All Articles

Entities mentioned with ALT

View All Entities